Quantcast

Latest Blood disorders Stories

2012-03-08 08:00:00

Cancer Monthly, the only centralized source of cancer treatment results, adds two new cancers to the database. Raleigh, NC (PRWEB) March 08, 2012 Cancer Monthly is proud to announce that it now provides treatment results for Non Hodgkin´s Lymphoma and Bladder Cancer. Cancer Monthly is the only centralized source of cancer treatment results. Founded more than seven years ago, Cancer Monthly now provides information on the actual performance for nearly 1,000 different treatments for...

2012-03-08 01:04:19

Study will lead to new approaches in the treatment of pediatric cancers A team of researchers at Case Western Reserve University School of Medicine has developed the first "theranostic" agent for the treatment of acute lymphoblastic leukemia (ALL). ALL is the most common type of childhood cancer diagnosed in approximately 5,000 new cases each year in the United States. The findings provide insight into pediatric oncology that specifically focuses on the development of "theranostic"...

2012-03-06 06:21:46

(Ivanhoe Newswire)-- Yale researchers have discovered how megakaryocytes or giant blood cells that produce wound healing platelets grow 10 or more times bigger than other blood cells and how they may cause a form of leukemia. "A failure of these cells to grow might be an initial trigger for megakaryoblastic leukemias," Diane Krause, senior researcher for the Yale Cancer Center, professor of laboratory medicine, cell biology, and pathology and associate director of the Yale Stem Cell...

2012-03-02 12:33:58

Findings could be a step toward developing better drugs for coronary artery disease and preventing heart attacks Researchers, led by scientists from Johns Hopkins, have found five previously unknown gene mutations believed to be associated with elevated blood platelet counts in African-Americans, findings they say could someday lead to the development of new drugs to help prevent coronary artery disease. The study is believed to be the first of its size to focus on platelet genetics in...

2012-03-02 05:54:12

(Ivanhoe Newswire) — It´s a disease that affects up to 3, 000 people each year and for sufferers of myelofibrosis, bone pain, bruising and fatigue are just some of the symptoms they live with every day. But now a new drug is changing the game. Myelofibrosis is caused by the accumulation of malignant bone marrow cells that triggers an inflammatory response, scarring the bone marrow and limiting its ability to produce blood, resulting in anemia. People who have myelofibrosis live...

2012-03-01 11:13:57

People with a blood cancer – myelofibrosis – can benefit from a drug called ruxolitinib, according to a randomized, double-blind, placebo-controlled clinical trial that included patients and researchers from the Stanford University School of Medicine. The results of the multi-site phase-3 trial, which will be published in the March 1 issue of the New England Journal of Medicine, led the Food and Drug Administration to approve the drug in November as treatment for people with...

2012-03-01 11:12:35

Ruxolitinib shrinks swollen spleens, eases debilitating symptoms of incurable malignancy A drug that relieves the severe symptoms of a life-threatening bone marrow cancer called myelofibrosis also improves the survival of patients with the disease, according to a phase III clinical trial published in the March 1 edition of New England Journal of Medicine. "The Phase I/II clinical trial showed that ruxolitinib improves quality of life for many patients with myelofibrosis and now this...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.